The Parliament of New Zealand voted last week on a new bill that would amends the country’s Misuse of Drugs Act of 1975, which would then open up medicinal cannabis for terminally ill patients to consume and possess.
The new bill would set regulations in place for “products manufactured, imported, and supplied under license…”, as well as set legislation in place to declassify Cannabidiol (CBD) as a controlled substance. CBD has recently gain global attention when the World Health Organization released a report asking for the compound to be declassified as a schedule 1 drugs around the world.
This move is seen as very progressive for a country that seems at least decades before a possible vote on cannabis legalization. The bill has now been given to the Parliament Health Committee for further discussion on the matter.
You may be interested
Liberty Health Sciences to Bring Mary’s Medicinals Cannabis Products to MassachusettsSam Rosenberg - May 26, 2018
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced this week that the company will expand the Company’s partnership with MM Technology Holdings, LLC to become the…
Top 5 Public Companies that Sells Cannabis and Industrial Hemp AgtechSam Rosenberg - May 25, 2018
Not every public company in the sector are involved in the cultivation and distribution of cannabinoid based products. There are a number of different companies involved in…
Thomas Jefferson University to Create Database to Track Medical Cannabis Patients’ Health OutcomesSam Rosenberg - May 25, 2018
Thomas Jefferson University in Philadelphia is in the process of developing a data base to register medical cannabis patients to study the positive or negative health benefits…